menu
    • menu

    Company profile for Instil Bio

    NEW Drugs in Dev: 5
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Instil Bio, Inc is a global, clinical-stage cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of cancer. We are building on the decades-long foundation of TIL efficacy in treating solid tumors, applying our cell therapy experience and TIL manufacturing platform to bring the promise of TIL therapy to patients in need. Instil Bio has research and cell therapy manufacturing facilities in Los ...
    Instil Bio, Inc is a global, clinical-stage cell therapy company developing tumor infiltrating lymphocytes (TIL) for the treatment of cancer. We are building on the decades-long foundation of TIL efficacy in treating solid tumors, applying our cell therapy experience and TIL manufacturing platform to bring the promise of TIL therapy to patients in need. Instil Bio has research and cell therapy manufacturing facilities in Los Angeles, CA and Manchester, UK, with corporate offices in Dallas, TX.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Instil BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Dallas, Texas
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://instilbio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Instil Bio Unveils 2025 Financials, Corporate Update
    Instil Bio Unveils 2025 Financials, Corporate Update

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3263677/0/en/Instil-Bio-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Instil's Stock Sinks After It Clears Out Clinical Pipeline
    Instil's Stock Sinks After It Clears Out Clinical Pipeline

    06 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/06/3213459/0/en/Instil-Bio-s-Subsidiary-Discontinues-Clinical-Development-of-AXN-2510-and-Terminates-License-and-Collaboration-Agreement-with-ImmuneOnco.html

    GLOBENEWSWIRE
    06 Jan 2026
    Share Share
    Instil Bio Reports Q3 2025 Financials And Corporate Update
    Instil Bio Reports Q3 2025 Financials And Corporate Update

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187151/0/en/Instil-Bio-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Instil Bio Reveals '2510 Monotherapy Data for 2L+ Squamous NSCLC
    Instil Bio Reveals '2510 Monotherapy Data for 2L+ Squamous NSCLC

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147631/0/en/Instil-Bio-Announces-ImmuneOnco-s-Presentation-of-2510-Monotherapy-Data-in-Patients-with-2L-Squamous-NSCLC-at-the-2025-World-Conference-on-Lung-Cancer-WCLC.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    Instil Bio's Q2 2025 Financial Results and Corporate Update
    Instil Bio's Q2 2025 Financial Results and Corporate Update

    13 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/13/3132376/0/en/Instil-Bio-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    13 Aug 2025
    Share Share
    Instil's PD-L1xVEGF Bispecific Shows Promise in China
    Instil's PD-L1xVEGF Bispecific Shows Promise in China

    31 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/instils-licensed-pd-l1xvegf-bispecific-shows-promise-china-instilling-hope-upcoming-us-test

    FIERCE BIOTECH
    31 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search